These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 21935949

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Drug Release and Nanodroplet Formation from Amorphous Solid Dispersions: Insight into the Roles of Drug Physicochemical Properties and Polymer Selection.
    Yang R, Mann AKP, Van Duong T, Ormes JD, Okoh GA, Hermans A, Taylor LS.
    Mol Pharm; 2021 May 03; 18(5):2066-2081. PubMed ID: 33784104
    [Abstract] [Full Text] [Related]

  • 23. Long-Term Physical Stability of PVP- and PVPVA-Amorphous Solid Dispersions.
    Lehmkemper K, Kyeremateng SO, Heinzerling O, Degenhardt M, Sadowski G.
    Mol Pharm; 2017 Jan 03; 14(1):157-171. PubMed ID: 28043133
    [Abstract] [Full Text] [Related]

  • 24. Applications of KinetiSol dispersing for the production of plasticizer free amorphous solid dispersions.
    DiNunzio JC, Brough C, Miller DA, Williams RO, McGinity JW.
    Eur J Pharm Sci; 2010 Jun 14; 40(3):179-87. PubMed ID: 20230894
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Influence of polymer molecular weight on in vitro dissolution behavior and in vivo performance of celecoxib:PVP amorphous solid dispersions.
    Knopp MM, Nguyen JH, Becker C, Francke NM, Jørgensen EB, Holm P, Holm R, Mu H, Rades T, Langguth P.
    Eur J Pharm Biopharm; 2016 Apr 14; 101():145-51. PubMed ID: 26899127
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Use of Polyvinyl Alcohol as a Solubility Enhancing Polymer for Poorly Water-Soluble Drug Delivery (Part 2).
    Brough C, Miller DA, Ellenberger D, Lubda D, Williams RO.
    AAPS PharmSciTech; 2016 Feb 14; 17(1):180-90. PubMed ID: 26863889
    [Abstract] [Full Text] [Related]

  • 30. Use of highly compressible Ceolus™ microcrystalline cellulose for improved dosage form properties containing a hydrophilic solid dispersion.
    Dinunzio JC, Schilling SU, Coney AW, Hughey JR, Kaneko N, McGinity JW.
    Drug Dev Ind Pharm; 2012 Feb 14; 38(2):180-9. PubMed ID: 21774741
    [Abstract] [Full Text] [Related]

  • 31. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
    Potter C, Tian Y, Walker G, McCoy C, Hornsby P, Donnelly C, Jones DS, Andrews GP.
    Mol Pharm; 2015 May 04; 12(5):1377-90. PubMed ID: 25730138
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Tailoring Release Profiles of BCS Class II Drugs Using Controlled Release Amorphous Solid Dispersion Beads with Membrane-Reservoir Design: Effect of Pore Former and Coating Levels.
    Lugtu-Pe JA, Lin BY, Chen K, Ghaffari A, Kane A, Wu XY.
    Mol Pharm; 2021 Nov 01; 18(11):4198-4209. PubMed ID: 34668379
    [Abstract] [Full Text] [Related]

  • 34. Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations.
    Guzmán HR, Tawa M, Zhang Z, Ratanabanangkoon P, Shaw P, Gardner CR, Chen H, Moreau JP, Almarsson O, Remenar JF.
    J Pharm Sci; 2007 Oct 01; 96(10):2686-702. PubMed ID: 17518357
    [Abstract] [Full Text] [Related]

  • 35. In Situ Salt Formation during Melt Extrusion for Improved Chemical Stability and Dissolution Performance of a Meloxicam-Copovidone Amorphous Solid Dispersion.
    Haser A, Cao T, Lubach JW, Zhang F.
    Mol Pharm; 2018 Mar 05; 15(3):1226-1237. PubMed ID: 29412681
    [Abstract] [Full Text] [Related]

  • 36. Combining crystalline and polymeric excipients in API solid dispersions - Opportunity or risk?
    Veith H, Wiechert F, Luebbert C, Sadowski G.
    Eur J Pharm Biopharm; 2021 Jan 05; 158():323-335. PubMed ID: 33296719
    [Abstract] [Full Text] [Related]

  • 37. Building a better particle: Leveraging physicochemical understanding of amorphous solid dispersions and a hierarchical particle approach for improved delivery at high drug loadings.
    Schenck L, Mann AKP, Liu Z, Milewski M, Zhang S, Ren J, Dewitt K, Hermans A, Cote A.
    Int J Pharm; 2019 Mar 25; 559():147-155. PubMed ID: 30654058
    [Abstract] [Full Text] [Related]

  • 38. Molecular implications of drug-polymer solubility in understanding the destabilization of solid dispersions by milling.
    Yang Z, Nollenberger K, Albers J, Qi S.
    Mol Pharm; 2014 Jul 07; 11(7):2453-65. PubMed ID: 24897345
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Evaluation of drug load and polymer by using a 96-well plate vacuum dry system for amorphous solid dispersion drug delivery.
    Chiang PC, Ran Y, Chou KJ, Cui Y, Sambrone A, Chan C, Hart R.
    AAPS PharmSciTech; 2012 Jun 07; 13(2):713-22. PubMed ID: 22562615
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.